Progressive Metastatic Castrate Resistant Prostate Cancer clinical trials

Explore recruiting progressive metastatic castrate resistant prostate cancer clinical trials.

Recruiting progressive metastatic castrate resistant prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Progressive Metastatic Castrate Resistant Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PSMAfore: A phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therapy in the Treatment of Taxane Naïve Men with Progressive Metastatic Castrate Resistant Prostate Cancer

Spain, Slovakia, Czechia, Sweden, Belgium, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Italy, Germany, Poland, France, Denmark, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Progressive Metastatic Castrate Resistant Prostate Cancer trials by city

Progressive Metastatic Castrate Resistant Prostate Cancer in Toronto Progressive Metastatic Castrate Resistant Prostate Cancer in Vancouver Progressive Metastatic Castrate Resistant Prostate Cancer in Montreal Progressive Metastatic Castrate Resistant Prostate Cancer in Calgary Progressive Metastatic Castrate Resistant Prostate Cancer in Edmonton Progressive Metastatic Castrate Resistant Prostate Cancer in Ottawa Progressive Metastatic Castrate Resistant Prostate Cancer in Winnipeg Progressive Metastatic Castrate Resistant Prostate Cancer in Quebec City Progressive Metastatic Castrate Resistant Prostate Cancer in Hamilton Progressive Metastatic Castrate Resistant Prostate Cancer in Kitchener Progressive Metastatic Castrate Resistant Prostate Cancer in London Progressive Metastatic Castrate Resistant Prostate Cancer in Halifax Progressive Metastatic Castrate Resistant Prostate Cancer in New York Progressive Metastatic Castrate Resistant Prostate Cancer in Los Angeles Progressive Metastatic Castrate Resistant Prostate Cancer in Chicago Progressive Metastatic Castrate Resistant Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease